首页 > 最新文献

Brain Research Bulletin最新文献

英文 中文
Alterations in dynamic regional homogeneity and functional connectivity in lung cancer patients with bone metastasis pain 肺癌骨转移性疼痛患者动态区域均匀性和功能连通性的改变
IF 3.7 3区 医学 Q2 NEUROSCIENCES Pub Date : 2025-12-02 DOI: 10.1016/j.brainresbull.2025.111670
Yu Tang , Tan Cheng , Lin Tang, Xiaoyu Zhou, Jing Zhang, Yong Tan, Hong Yu, Jing Yang, Daihong Liu, Jiuquan Zhang

Background

Although previous neuroimaging studies have characterized static brain activity in bone metastasis pain (BMP), its dynamic functional properties remain largely unexplored. This study aimed to investigate the dynamic brain activity in BMP patients.

Methods

We analyzed dynamic regional homogeneity (dReHo) and dynamic functional connectivity (dFC) in 50 right-handed lung cancer patients with BMP(+), 36 without BMP(−), and 32 healthy controls (HCs). Spearman’s correlation was used to evaluate associations with clinical variables.

Results

Compared to BMP(−) patients, BMP(+) patients exhibited increased dReHo variability in the right putamen, fusiform gyrus, left middle occipital gyrus (MOG), and left cerebellar lobule VIII (cerebellum_8_L). Relative to HCs, BMP(+) patients showed increased dReHo in the cerebellum_8_L and decreased dReHo in the left anterior cingulate cortex, right inferior temporal gyrus, and frontal lobe. BMP(−) patients displayed decreased dReHo in the right rolandic operculum and putamen compared to HCs. In BMP(+) patients, dReHo variability in the left MOG was positively correlated with pain intensity, while dReHo variability in the right fusiform gyrus was negatively associated with anxiety. Enhanced dFC was observed between the right fusiform/left MOG and cerebellar subregions in BMP(+) compared to BMP(−) patients.

Conclusions

This study demonstrates abnormal dynamic brain activity within visual, affective, and sensorimotor networks in patients with BMP. These findings suggest that dReHo/dFC variability may serve as a neuroimaging biomarker for BMP diagnosis and disease monitoring. Furthermore, they provide new insights into the neurophysiological mechanisms of BMP and identify promising targets for neuromodulation-based therapeutic interventions.
虽然以前的神经影像学研究已经描述了骨转移性疼痛(BMP)的静态脑活动,但其动态功能特性仍未被广泛探索。本研究旨在探讨BMP患者的动态脑活动。方法对50例伴有BMP(+)、36例无BMP(-)和32例健康对照(hc)的右撇子肺癌患者进行动态区域均匀性(dReHo)和动态功能连通性(dFC)分析。Spearman相关性用于评价与临床变量的关联。结果与BMP(−)患者相比,BMP(+)患者在右侧壳核、梭状回、左侧枕中回(MOG)和左侧小脑VIII (cerebellum_8_L)中表现出更高的dReHo变异性。与hc相比,BMP(+)患者小脑_8_l dReHo升高,左侧前扣带皮层、右侧颞下回和额叶dReHo降低。与hcc患者相比,BMP(−)患者右侧罗兰包膜和硬膜的dReHo减少。在BMP(+)患者中,左侧MOG的dReHo变异性与疼痛强度呈正相关,而右侧梭状回的dReHo变异性与焦虑呈负相关。与BMP(-)患者相比,BMP(+)患者的右侧梭状回/左侧MOG和小脑亚区之间的dFC增强。结论:本研究表明BMP患者的视觉、情感和感觉运动网络中存在异常的动态脑活动。这些发现表明,dReHo/dFC可变性可以作为BMP诊断和疾病监测的神经成像生物标志物。此外,它们为BMP的神经生理机制提供了新的见解,并确定了基于神经调节的治疗干预的有希望的靶点。
{"title":"Alterations in dynamic regional homogeneity and functional connectivity in lung cancer patients with bone metastasis pain","authors":"Yu Tang ,&nbsp;Tan Cheng ,&nbsp;Lin Tang,&nbsp;Xiaoyu Zhou,&nbsp;Jing Zhang,&nbsp;Yong Tan,&nbsp;Hong Yu,&nbsp;Jing Yang,&nbsp;Daihong Liu,&nbsp;Jiuquan Zhang","doi":"10.1016/j.brainresbull.2025.111670","DOIUrl":"10.1016/j.brainresbull.2025.111670","url":null,"abstract":"<div><h3>Background</h3><div>Although previous neuroimaging studies have characterized static brain activity in bone metastasis pain (BMP), its dynamic functional properties remain largely unexplored. This study aimed to investigate the dynamic brain activity in BMP patients.</div></div><div><h3>Methods</h3><div>We analyzed dynamic regional homogeneity (dReHo) and dynamic functional connectivity (dFC) in 50 right-handed lung cancer patients with BMP(+), 36 without BMP(−), and 32 healthy controls (HCs). Spearman’s correlation was used to evaluate associations with clinical variables.</div></div><div><h3>Results</h3><div>Compared to BMP(−) patients, BMP(+) patients exhibited increased dReHo variability in the right putamen, fusiform gyrus, left middle occipital gyrus (MOG), and left cerebellar lobule VIII (cerebellum_8_L). Relative to HCs, BMP(+) patients showed increased dReHo in the cerebellum_8_L and decreased dReHo in the left anterior cingulate cortex, right inferior temporal gyrus, and frontal lobe. BMP(−) patients displayed decreased dReHo in the right rolandic operculum and putamen compared to HCs. In BMP(+) patients, dReHo variability in the left MOG was positively correlated with pain intensity, while dReHo variability in the right fusiform gyrus was negatively associated with anxiety. Enhanced dFC was observed between the right fusiform/left MOG and cerebellar subregions in BMP(+) compared to BMP(−) patients.</div></div><div><h3>Conclusions</h3><div>This study demonstrates abnormal dynamic brain activity within visual, affective, and sensorimotor networks in patients with BMP. These findings suggest that dReHo/dFC variability may serve as a neuroimaging biomarker for BMP diagnosis and disease monitoring. Furthermore, they provide new insights into the neurophysiological mechanisms of BMP and identify promising targets for neuromodulation-based therapeutic interventions.</div></div>","PeriodicalId":9302,"journal":{"name":"Brain Research Bulletin","volume":"234 ","pages":"Article 111670"},"PeriodicalIF":3.7,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145658693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Forced and voluntary exercise exert differential neuroprotective effects in cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and blood-brain barrier disruption 强迫运动和自愿运动通过抑制中性粒细胞浸润和血脑屏障破坏在脑缺血再灌注损伤中发挥不同的神经保护作用。
IF 3.7 3区 医学 Q2 NEUROSCIENCES Pub Date : 2025-12-02 DOI: 10.1016/j.brainresbull.2025.111668
Manyao Zou , Jie Wang , Long Yu , Yuqing Bi , Guofeng Yan , Hanqing Ding , Ying Zhang
Ischemic stroke is associated with high disability rates, underscoring the urgent need for effective rehabilitation strategies. While exercise rehabilitation promotes functional recovery, the differential therapeutic effects of distinct exercise modalities and their underlying mechanisms remain incompletely understood. Our previous proteomic study showed that exercise administered after cerebral ischemia-reperfusion (CI/RP) strongly inhibited major neutrophil-driven biological processes in the penumbra region, including neutrophil extracellular traps (NETs) formation and integrin-cell surface interactions. Subsequent experimental results demonstrated that forced exercise (F-Ex) more significantly reduced neutrophil infiltration and NETs formation, attenuated blood-brain barrier(BBB)leakage, and upregulated tight junction proteins (TJPs) compared to voluntary exercise (V-Ex). Furthermore, previous studies have established that matrix metalloproteinases (MMPs) are closely linked to BBB disruption. In our study, matrix metalloproteinase-25 (MMP-25/MT6-MMP), was recognized among the most differentially expressed proteins (DEPs) and its expression was associated with neutrophil infiltration. However, the role of MMP-25 in cerebral ischemia remains understudied. Overall, F-Ex conferred greater neurological improvement in early-stage CI/RP injury compared to V-Ex. These results provide evidence-based insights for selecting optimal exercise interventions in post-stroke rehabilitation, elucidate a novel mechanism underlying F-Ex-mediated protection against ischemic brain injury, and implicate MMP-25 as a potential therapeutic target for ischemic stroke.
缺血性卒中与高致残率相关,因此迫切需要有效的康复策略。虽然运动康复促进功能恢复,但不同运动方式的不同治疗效果及其潜在机制仍未完全了解。我们之前的蛋白质组学研究表明,脑缺血再灌注(CI/RP)后进行的运动强烈抑制了半影区中性粒细胞驱动的主要生物过程,包括中性粒细胞胞外陷阱(NETs)的形成和整合素-细胞表面相互作用。随后的实验结果表明,与自愿运动(V-Ex)相比,强迫运动(F-Ex)更显著地减少了中性粒细胞浸润和NETs的形成,减弱了血脑屏障(BBB)渗漏,并上调了紧密连接蛋白(TJPs)。此外,先前的研究已经确定基质金属蛋白酶(MMPs)与血脑屏障破坏密切相关。在我们的研究中,基质金属蛋白酶25 (MMP-25/MT6-MMP)被认为是最差异表达的蛋白(DEPs)之一,其表达与中性粒细胞浸润有关。然而,MMP-25在脑缺血中的作用仍未得到充分研究。总体而言,与V-Ex相比,F-Ex对早期CI/RP损伤的神经系统改善更大。这些结果为卒中后康复中选择最佳运动干预措施提供了基于证据的见解,阐明了f - ex介导的缺血性脑损伤保护的新机制,并暗示MMP-25是缺血性卒中的潜在治疗靶点。
{"title":"Forced and voluntary exercise exert differential neuroprotective effects in cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and blood-brain barrier disruption","authors":"Manyao Zou ,&nbsp;Jie Wang ,&nbsp;Long Yu ,&nbsp;Yuqing Bi ,&nbsp;Guofeng Yan ,&nbsp;Hanqing Ding ,&nbsp;Ying Zhang","doi":"10.1016/j.brainresbull.2025.111668","DOIUrl":"10.1016/j.brainresbull.2025.111668","url":null,"abstract":"<div><div>Ischemic stroke is associated with high disability rates, underscoring the urgent need for effective rehabilitation strategies. While exercise rehabilitation promotes functional recovery, the differential therapeutic effects of distinct exercise modalities and their underlying mechanisms remain incompletely understood. Our previous proteomic study showed that exercise administered after cerebral ischemia-reperfusion (CI/RP) strongly inhibited major neutrophil-driven biological processes in the penumbra region, including neutrophil extracellular traps (NETs) formation and integrin-cell surface interactions. Subsequent experimental results demonstrated that forced exercise (F-Ex) more significantly reduced neutrophil infiltration and NETs formation, attenuated blood-brain barrier(BBB)leakage, and upregulated tight junction proteins (TJPs) compared to voluntary exercise (V-Ex). Furthermore, previous studies have established that matrix metalloproteinases (MMPs) are closely linked to BBB disruption. In our study, matrix metalloproteinase-25 (MMP-25/MT6-MMP), was recognized among the most differentially expressed proteins (DEPs) and its expression was associated with neutrophil infiltration. However, the role of MMP-25 in cerebral ischemia remains understudied. Overall, F-Ex conferred greater neurological improvement in early-stage CI/RP injury compared to V-Ex. These results provide evidence-based insights for selecting optimal exercise interventions in post-stroke rehabilitation, elucidate a novel mechanism underlying F-Ex-mediated protection against ischemic brain injury, and implicate MMP-25 as a potential therapeutic target for ischemic stroke.</div></div>","PeriodicalId":9302,"journal":{"name":"Brain Research Bulletin","volume":"234 ","pages":"Article 111668"},"PeriodicalIF":3.7,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145676625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abnormal dynamic connectivity patterns in self-limited epilepsy with centrotemporal spikes 伴有中央颞叶尖峰的自限性癫痫的异常动态连接模式。
IF 3.7 3区 医学 Q2 NEUROSCIENCES Pub Date : 2025-12-02 DOI: 10.1016/j.brainresbull.2025.111669
Xu Chen , Linfeng Song , Jiaren Zhang , Xuejin Ma , Binlin Tian , Yongzhe Li , Anjie Zhang , Xiyao Yang , Yiyun Zhang , Tijiang Zhang , Lin Jiang

Objective

To characterize the dynamic functional network connectivity (dFNC) patterns in children with self-limited epilepsy with centrotemporal spikes (SeLECTS) and to uncover potential abnormalities in neural regulation and related functional impairments.

Materials and methods

Resting-state functional magnetic resonance imaging (rs-fMRI) data were collected from 61 children with SeLECTS and 69 healthy controls (HCs). Independent component analysis (ICA), the sliding window approach and hidden markov modeling (HMM) were employed to systematically investigate potential differences in dFNC properties between the two groups.

Results

The dFNC analysis identified four dynamic states, with State 1 occurring most frequently. State 1 and State 3 represented two polarized connectivity patterns, with State 1 characterized by weak/negative connections and State 3 by widespread strong connections. In both states, children with SeLECTS showed significantly reduced connectivity within the dorsal attention network (DAN) compared with HCs (p < 0.001, FDR-corrected). In the connectivity-balanced State 2, children with SeLECTS showed significantly reduced fractional windows (p = 0.009) and mean dwell time (p = 0.018) compared with HCs, whereas no significant differences were observed in State 4. In addition, temporal variability of functional connectivity between the DAN and visual network (VIS) was significantly reduced in SeLECTS (p < 0.001, FDR-corrected), and this variability was positively correlated with full-scale intelligence quotient (FIQ) (p < 0.05). HMM results from another dynamic perspective further confirmed and echoed the above abnormalities.

Conclusion

This study revealed abnormal dynamic connectivity patterns of brain networks in children with SeLECTS from a multidimensional dynamic perspective. These macroscopic abnormalities may reflect an underlying excitation–inhibition imbalance in neural networks and provide new insights into brain functional reorganization and the potential neurobiological mechanisms of SeLECTS.
目的:研究伴有中央颞叶尖峰(SeLECTS)的自限性癫痫患儿的动态功能网络连接(dFNC)模式,揭示神经调节的潜在异常和相关功能损伤。材料与方法:收集61例select患儿和69例健康对照(hc)静息状态功能磁共振成像(rs-fMRI)数据。采用独立分量分析(ICA)、滑动窗口方法和隐马尔可夫模型(HMM)系统地研究了两组间dFNC特性的潜在差异。结果:dFNC分析确定了四种动态状态,状态1发生频率最高。状态1和状态3呈现两种极化的连接模式,状态1以弱/负连接为特征,状态3以广泛的强连接为特征。在这两种状态下,与hc相比,select儿童在背侧注意网络(DAN)内的连通性显著降低(p < 0.001,经fdr校正)。在连接平衡状态2中,与hc相比,select儿童的分数窗口(p = 0.009)和平均停留时间(p = 0.018)显著减少,而在状态4中没有观察到显著差异。此外,选择组DAN和视觉网络(VIS)功能连接的时间变异性显著降低(p < 0.001,经fdr校正),且这种变异性与全面智商(FIQ)呈正相关(p < 0.05)。另一个动态角度的HMM结果进一步证实和呼应了上述异常。结论:本研究从多维动态角度揭示了select儿童脑网络异常的动态连接模式。这些宏观异常可能反映了神经网络中潜在的兴奋-抑制失衡,并为脑功能重组和潜在的神经生物学机制提供了新的见解。
{"title":"Abnormal dynamic connectivity patterns in self-limited epilepsy with centrotemporal spikes","authors":"Xu Chen ,&nbsp;Linfeng Song ,&nbsp;Jiaren Zhang ,&nbsp;Xuejin Ma ,&nbsp;Binlin Tian ,&nbsp;Yongzhe Li ,&nbsp;Anjie Zhang ,&nbsp;Xiyao Yang ,&nbsp;Yiyun Zhang ,&nbsp;Tijiang Zhang ,&nbsp;Lin Jiang","doi":"10.1016/j.brainresbull.2025.111669","DOIUrl":"10.1016/j.brainresbull.2025.111669","url":null,"abstract":"<div><h3>Objective</h3><div>To characterize the dynamic functional network connectivity (dFNC) patterns in children with self-limited epilepsy with centrotemporal spikes (SeLECTS) and to uncover potential abnormalities in neural regulation and related functional impairments.</div></div><div><h3>Materials and methods</h3><div>Resting-state functional magnetic resonance imaging (rs-fMRI) data were collected from 61 children with SeLECTS and 69 healthy controls (HCs). Independent component analysis (ICA), the sliding window approach and hidden markov modeling (HMM) were employed to systematically investigate potential differences in dFNC properties between the two groups.</div></div><div><h3>Results</h3><div>The dFNC analysis identified four dynamic states, with State 1 occurring most frequently. State 1 and State 3 represented two polarized connectivity patterns, with State 1 characterized by weak/negative connections and State 3 by widespread strong connections. In both states, children with SeLECTS showed significantly reduced connectivity within the dorsal attention network (DAN) compared with HCs (<em>p</em> &lt; 0.001, FDR-corrected). In the connectivity-balanced State 2, children with SeLECTS showed significantly reduced fractional windows (<em>p</em> = 0.009) and mean dwell time (<em>p</em> = 0.018) compared with HCs, whereas no significant differences were observed in State 4. In addition, temporal variability of functional connectivity between the DAN and visual network (VIS) was significantly reduced in SeLECTS (<em>p</em> &lt; 0.001, FDR-corrected), and this variability was positively correlated with full-scale intelligence quotient (FIQ) (<em>p</em> &lt; 0.05). HMM results from another dynamic perspective further confirmed and echoed the above abnormalities.</div></div><div><h3>Conclusion</h3><div>This study revealed abnormal dynamic connectivity patterns of brain networks in children with SeLECTS from a multidimensional dynamic perspective. These macroscopic abnormalities may reflect an underlying excitation–inhibition imbalance in neural networks and provide new insights into brain functional reorganization and the potential neurobiological mechanisms of SeLECTS.</div></div>","PeriodicalId":9302,"journal":{"name":"Brain Research Bulletin","volume":"234 ","pages":"Article 111669"},"PeriodicalIF":3.7,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145676631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A critical appraisal of drug transport across the blood-brain barrier: Evaluation using new-age microfluidic technique 通过血脑屏障的药物运输的关键评价:评价使用新时代的微流体技术。
IF 3.7 3区 医学 Q2 NEUROSCIENCES Pub Date : 2025-12-02 DOI: 10.1016/j.brainresbull.2025.111662
Kiran Marathe , Dhruv Sanjay Gupta , Kalyani Barve , Dhananjay Bodas
Research over the past few decades has focused on elucidating the role of the blood-brain barrier (BBB) in neuroprotection, regulation of the brain microenvironment, and mediation of the selective permeability of substances, including drug molecules. This has highlighted its significance in preclinical research, particularly in the screening of novel chemical entities with neuromodulatory properties. The BBB is not a static barrier but a dynamic, multicellular interface known as the neurovascular unit (NVU), which actively regulates brain homeostasis. A persistent challenge in neurotherapeutics is the translatability crisis, where promising results from traditional preclinical models fail to materialize in human trials. Current in vivo models, such as those using rodents and zebrafish, replicate the complexity of the human BBB and demonstrate satisfactory reproducibility, but are limited by their cost, time-consuming nature, and critical issues of interspecies translatability, particularly in the expression and function of key drug transporters. This has driven the development of in vitro models. In recent years, organ-on-a-chip technologies, which utilize the principles of microfluidics, have emerged at the forefront. These models are robust, cost-effective, and enable high-throughput screening of experimental results. By incorporating human-derived cells, physiological shear stress, and 3D architecture, these platforms are evolving from simple permeability-screening tools into sophisticated "pathophysiology-in-a-dish" systems. They combine the advantages of both in vivo and in vitro systems and offer promising scalability for modeling neurodegenerative diseases, neuroinflammation, and cancer, thereby enabling more predictive screening of therapeutic candidates. This review aims to provide a perspective on the current understanding of the BBB and its associated transport mechanisms, followed by a discussion of various contemporary models with the potential to transform the drug discovery landscape. The application of microfluidics in designing these models, along with noteworthy case studies in disease modeling, is explored. Finally, a brief overview of current challenges in the field, including the need for standardization, and exciting future directions spurred by regulatory shifts toward non-animal alternative methods is presented.
过去几十年的研究重点是阐明血脑屏障(BBB)在神经保护、脑微环境调节和物质(包括药物分子)选择性渗透中的作用。这突出了它在临床前研究中的重要性,特别是在筛选具有神经调节特性的新型化学实体方面。血脑屏障不是一个静态屏障,而是一个动态的多细胞界面,被称为神经血管单元(NVU),它积极调节大脑的内稳态。神经治疗学中一个持续的挑战是可译性危机,传统临床前模型的有希望的结果未能在人体试验中实现。目前的体内模型,如使用啮齿动物和斑马鱼的模型,复制了人类血脑屏障的复杂性,并表现出令人满意的可重复性,但受到成本、耗时和种间可翻译性的关键问题的限制,特别是在关键药物转运体的表达和功能方面。这推动了体外模型的发展。近年来,利用微流控原理的器官芯片技术已经走在了前沿。这些模型是稳健的,具有成本效益的,并且能够对实验结果进行高通量筛选。通过结合人源性细胞、生理剪切应力和3D结构,这些平台正在从简单的渗透性筛选工具演变为复杂的“盘中病理生理”系统。它们结合了体内和体外系统的优势,为神经退行性疾病、神经炎症和癌症的建模提供了有前途的可扩展性,从而能够对治疗候选物进行更具预测性的筛选。本综述旨在提供对血脑屏障及其相关运输机制的当前理解的观点,随后讨论了各种具有改变药物发现前景潜力的当代模型。探讨了微流体在设计这些模型中的应用,以及在疾病建模中值得注意的案例研究。最后,简要概述了该领域当前的挑战,包括标准化的需要,以及由向非动物替代方法的监管转变所刺激的令人兴奋的未来方向。
{"title":"A critical appraisal of drug transport across the blood-brain barrier: Evaluation using new-age microfluidic technique","authors":"Kiran Marathe ,&nbsp;Dhruv Sanjay Gupta ,&nbsp;Kalyani Barve ,&nbsp;Dhananjay Bodas","doi":"10.1016/j.brainresbull.2025.111662","DOIUrl":"10.1016/j.brainresbull.2025.111662","url":null,"abstract":"<div><div>Research over the past few decades has focused on elucidating the role of the blood-brain barrier (BBB) in neuroprotection, regulation of the brain microenvironment, and mediation of the selective permeability of substances, including drug molecules. This has highlighted its significance in preclinical research, particularly in the screening of novel chemical entities with neuromodulatory properties. The BBB is not a static barrier but a dynamic, multicellular interface known as the neurovascular unit (NVU), which actively regulates brain homeostasis. A persistent challenge in neurotherapeutics is the translatability crisis, where promising results from traditional preclinical models fail to materialize in human trials. Current <em>in vivo</em> models, such as those using rodents and zebrafish, replicate the complexity of the human BBB and demonstrate satisfactory reproducibility, but are limited by their cost, time-consuming nature, and critical issues of interspecies translatability, particularly in the expression and function of key drug transporters. This has driven the development of <em>in vitro</em> models. In recent years, organ-on-a-chip technologies, which utilize the principles of microfluidics, have emerged at the forefront. These models are robust, cost-effective, and enable high-throughput screening of experimental results. By incorporating human-derived cells, physiological shear stress, and 3D architecture, these platforms are evolving from simple permeability-screening tools into sophisticated \"pathophysiology-in-a-dish\" systems. They combine the advantages of both <em>in vivo</em> and <em>in vitro</em> systems and offer promising scalability for modeling neurodegenerative diseases, neuroinflammation, and cancer, thereby enabling more predictive screening of therapeutic candidates. This review aims to provide a perspective on the current understanding of the BBB and its associated transport mechanisms, followed by a discussion of various contemporary models with the potential to transform the drug discovery landscape. The application of microfluidics in designing these models, along with noteworthy case studies in disease modeling, is explored. Finally, a brief overview of current challenges in the field, including the need for standardization, and exciting future directions spurred by regulatory shifts toward non-animal alternative methods is presented.</div></div>","PeriodicalId":9302,"journal":{"name":"Brain Research Bulletin","volume":"234 ","pages":"Article 111662"},"PeriodicalIF":3.7,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145676599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DHX9 aggravates epilepsy by promoting STAT1 phosphorylation to increase oxidative stress and apoptosis DHX9通过促进STAT1磷酸化增加氧化应激和细胞凋亡而加重癫痫。
IF 3.7 3区 医学 Q2 NEUROSCIENCES Pub Date : 2025-12-01 DOI: 10.1016/j.brainresbull.2025.111650
Hong Chen , Qiannan Song , Da-Qing Feng

Background

DEAH-box helicase 9 (DHX9), as a member of the RNA helicase family, plays important roles in various diseases, but its specific function and molecular mechanisms in epilepsy remain unclear. This study aims to investigate the role of DHX9 in epilepsy and its interaction mechanisms with STAT1.

Methods

Acute and chronic epilepsy mouse models induced by pentylenetetrazole (PTZ) and kainic acid (KA)-induced epilepsy mouse models were established to detect DHX9 expression levels in hippocampal tissue. In vitro epilepsy models were established using HT22 mouse hippocampal neuronal cell lines and BV2 microglial cell lines to analyze DHX9 expression changes. Co-immunoprecipitation was employed to detect protein-protein interactions between DHX9 and STAT1. STAT1-specific inhibitors were used in rescue experiments to validate the critical role of STAT1 in DHX9-mediated pathogenic effects. Western blot and immunofluorescence staining were used to detect oxidative stress markers and apoptosis-related indicators.

Results

DHX9 expression was upregulated in hippocampal tissue from PTZ-induced acute and chronic epilepsy mice and KA-induced epilepsy mice. In vitro experiments confirmed that DHX9 expression was similarly increased in epilepsy models constructed with HT22 neurons and BV2 microglia. Functional studies demonstrated that DHX9 overexpression aggravated neuronal injury, including increased apoptosis rate, elevated oxidative stress levels, and promoted inflammatory responses. Conversely, silencing DHX9 through shRNA reduced neuronal injury in KA-induced epilepsy mouse models. Mechanistic studies revealed that DHX9 silencing exerted neuroprotective effects by inhibiting the STAT1 signaling pathway, reducing oxidative stress and apoptosis. Co-immunoprecipitation experiments confirmed direct protein-protein interactions between DHX9 and STAT1. Rescue experiments further demonstrated that STAT1-specific inhibitors could reverse DHX9 overexpression-induced neuronal injury, proving that STAT1 is a key downstream molecule mediating DHX9's pathogenic effects.

Conclusion

This study reveals the important role of DHX9 in epilepsy pathogenesis and elucidates the molecular mechanism by which DHX9 directly interacts with STAT1 and promotes its phosphorylation, thereby activating downstream oxidative stress and apoptotic signaling pathways, ultimately aggravating epileptic neuronal injury.
背景:DEAH-box解旋酶9 (DHX9)作为RNA解旋酶家族的一员,在多种疾病中发挥重要作用,但其在癫痫中的具体功能和分子机制尚不清楚。本研究旨在探讨DHX9在癫痫中的作用及其与STAT1的相互作用机制。方法:建立戊四唑(PTZ)诱导的急、慢性癫痫小鼠模型和kainic acid (KA)诱导的癫痫小鼠模型,检测海马组织中DHX9的表达水平。采用HT22小鼠海马神经元细胞系和BV2小胶质细胞系建立体外癫痫模型,分析DHX9表达变化。采用免疫共沉淀法检测DHX9与STAT1之间的蛋白相互作用。在救援实验中使用STAT1特异性抑制剂来验证STAT1在dhx9介导的致病作用中的关键作用。Western blot和免疫荧光染色检测氧化应激标志物和细胞凋亡相关指标。结果:ptz诱导的急、慢性癫痫小鼠和ka诱导的癫痫小鼠海马组织中DHX9表达上调。体外实验证实,DHX9在HT22神经元和BV2小胶质细胞构建的癫痫模型中表达同样增加。功能研究表明,DHX9过表达加重了神经元损伤,包括细胞凋亡率升高、氧化应激水平升高、炎症反应增强。相反,通过shRNA沉默DHX9可减少ka诱导癫痫小鼠模型中的神经元损伤。机制研究表明,DHX9沉默通过抑制STAT1信号通路、减少氧化应激和细胞凋亡发挥神经保护作用。共免疫沉淀实验证实了DHX9与STAT1之间的直接蛋白蛋白相互作用。救援实验进一步证实,STAT1特异性抑制剂可逆转DHX9过表达诱导的神经元损伤,证明STAT1是介导DHX9致病作用的关键下游分子。结论:本研究揭示了DHX9在癫痫发病中的重要作用,阐明了DHX9直接与STAT1相互作用,促进其磷酸化,进而激活下游氧化应激和凋亡信号通路,最终加重癫痫神经元损伤的分子机制。
{"title":"DHX9 aggravates epilepsy by promoting STAT1 phosphorylation to increase oxidative stress and apoptosis","authors":"Hong Chen ,&nbsp;Qiannan Song ,&nbsp;Da-Qing Feng","doi":"10.1016/j.brainresbull.2025.111650","DOIUrl":"10.1016/j.brainresbull.2025.111650","url":null,"abstract":"<div><h3>Background</h3><div>DEAH-box helicase 9 (DHX9), as a member of the RNA helicase family, plays important roles in various diseases, but its specific function and molecular mechanisms in epilepsy remain unclear. This study aims to investigate the role of DHX9 in epilepsy and its interaction mechanisms with STAT1.</div></div><div><h3>Methods</h3><div>Acute and chronic epilepsy mouse models induced by pentylenetetrazole (PTZ) and kainic acid (KA)-induced epilepsy mouse models were established to detect DHX9 expression levels in hippocampal tissue. In vitro epilepsy models were established using HT22 mouse hippocampal neuronal cell lines and BV2 microglial cell lines to analyze DHX9 expression changes. Co-immunoprecipitation was employed to detect protein-protein interactions between DHX9 and STAT1. STAT1-specific inhibitors were used in rescue experiments to validate the critical role of STAT1 in DHX9-mediated pathogenic effects. Western blot and immunofluorescence staining were used to detect oxidative stress markers and apoptosis-related indicators.</div></div><div><h3>Results</h3><div>DHX9 expression was upregulated in hippocampal tissue from PTZ-induced acute and chronic epilepsy mice and KA-induced epilepsy mice. In vitro experiments confirmed that DHX9 expression was similarly increased in epilepsy models constructed with HT22 neurons and BV2 microglia. Functional studies demonstrated that DHX9 overexpression aggravated neuronal injury, including increased apoptosis rate, elevated oxidative stress levels, and promoted inflammatory responses. Conversely, silencing DHX9 through shRNA reduced neuronal injury in KA-induced epilepsy mouse models. Mechanistic studies revealed that DHX9 silencing exerted neuroprotective effects by inhibiting the STAT1 signaling pathway, reducing oxidative stress and apoptosis. Co-immunoprecipitation experiments confirmed direct protein-protein interactions between DHX9 and STAT1. Rescue experiments further demonstrated that STAT1-specific inhibitors could reverse DHX9 overexpression-induced neuronal injury, proving that STAT1 is a key downstream molecule mediating DHX9's pathogenic effects.</div></div><div><h3>Conclusion</h3><div>This study reveals the important role of DHX9 in epilepsy pathogenesis and elucidates the molecular mechanism by which DHX9 directly interacts with STAT1 and promotes its phosphorylation, thereby activating downstream oxidative stress and apoptotic signaling pathways, ultimately aggravating epileptic neuronal injury.</div></div>","PeriodicalId":9302,"journal":{"name":"Brain Research Bulletin","volume":"233 ","pages":"Article 111650"},"PeriodicalIF":3.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145586080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prefrontal neurophysiological changes associated with subanesthetic esketamine accelerating mice emergence from propofol anesthesia 亚麻醉艾氯胺酮加速异丙酚麻醉小鼠苏醒相关的前额叶神经生理变化。
IF 3.7 3区 医学 Q2 NEUROSCIENCES Pub Date : 2025-12-01 DOI: 10.1016/j.brainresbull.2025.111648
Yinying Sun , Bo Li , Yiting Wang , Xuliang Jiang , Su Tang , Jiayi Zhang , Jun Zhang

Background

Recent studies have demonstrated that subanesthetic dose of ketamine or its S-enantiomer, esketamine, can paradoxically accelerate the recovery of consciousness in rodents following general anesthesia. However, the neural mechanisms underlying this "awakening-promoting" effect remain poorly understood.

Methods

Adult C57BL/6 J mice were anesthetized with propofol, 0and a low dose of esketamine (2 mg/kg) was administered intravenously to assess its awakening effects through behavioral tests. In vivo multichannel electrophysiological recordings, calcium imaging, and two-photon imaging combined with neurotransmitter probes targeting 5-hydroxytryptamine(5-HT) and acetylcholine (ACh) were employed to investigate electrophysiological and neurochemical dynamics in the prefrontal cortex (PFC) during the awakening process.

Results

Subanesthetic esketamine significantly accelerated awakening from propofol anesthesia in mice. In the PFC, esketamine hastened the emergence of γ oscillations and triggered earlier activation of neuronal somata and dendrites in layer V, while delaying activation in layer II/III neurons. Additionally, subanesthetic esketamine induced inter-layer phase desynchronization and a premature increase in ACh and 5-HT levels in the PFC during the awakening process.

Conclusion

Our findings suggest that low-dose esketamine facilitates mice awakening from propofol anesthesia may by orchestrating a sequence of neural events in the PFC. This study provides novel mechanistic insight into the paradoxical emergence from anesthesia induced by subanesthetic esketamine/ketamine.
背景:最近的研究表明,亚麻醉剂量的氯胺酮或其s -对体艾氯胺酮可以矛盾地加速啮齿动物全身麻醉后的意识恢复。然而,这种“唤醒促进”效应背后的神经机制仍然知之甚少。方法:用异丙酚麻醉C57BL/6J成年小鼠,并静脉注射小剂量艾氯胺酮(2mg/kg),通过行为学试验评价其唤醒作用。采用体内多通道电生理记录、钙成像和双光子成像结合靶向5-羟色胺(5-HT)和乙酰胆碱(ACh)的神经递质探针,研究了觉醒过程中前额叶皮层(PFC)的电生理和神经化学动力学。结果:亚麻醉艾氯胺酮显著加速异丙酚麻醉小鼠苏醒。在PFC中,艾氯胺酮加速了γ振荡的出现,并触发了V层神经元体和树突的早期激活,而延迟了II/III层神经元的激活。此外,亚麻醉艾氯胺酮诱导觉醒过程中PFC的层间相不同步和乙酰胆碱和5-羟色胺水平的过早增加。结论:我们的研究结果表明,低剂量艾氯胺酮可能通过在pfc中安排一系列神经事件来促进小鼠从异丙酚麻醉中醒来。这项研究为亚麻醉艾氯胺酮/氯胺酮诱导的麻醉中出现的矛盾提供了新的机制见解。
{"title":"Prefrontal neurophysiological changes associated with subanesthetic esketamine accelerating mice emergence from propofol anesthesia","authors":"Yinying Sun ,&nbsp;Bo Li ,&nbsp;Yiting Wang ,&nbsp;Xuliang Jiang ,&nbsp;Su Tang ,&nbsp;Jiayi Zhang ,&nbsp;Jun Zhang","doi":"10.1016/j.brainresbull.2025.111648","DOIUrl":"10.1016/j.brainresbull.2025.111648","url":null,"abstract":"<div><h3>Background</h3><div>Recent studies have demonstrated that subanesthetic dose of ketamine or its S-enantiomer, esketamine, can paradoxically accelerate the recovery of consciousness in rodents following general anesthesia. However, the neural mechanisms underlying this \"awakening-promoting\" effect remain poorly understood.</div></div><div><h3>Methods</h3><div>Adult C57BL/6 J mice were anesthetized with propofol, 0and a low dose of esketamine (2 mg/kg) was administered intravenously to assess its awakening effects through behavioral tests. In vivo multichannel electrophysiological recordings, calcium imaging, and two-photon imaging combined with neurotransmitter probes targeting 5-hydroxytryptamine(5-HT) and acetylcholine (ACh) were employed to investigate electrophysiological and neurochemical dynamics in the prefrontal cortex (PFC) during the awakening process.</div></div><div><h3>Results</h3><div>Subanesthetic esketamine significantly accelerated awakening from propofol anesthesia in mice. In the PFC, esketamine hastened the emergence of γ oscillations and triggered earlier activation of neuronal somata and dendrites in layer V, while delaying activation in layer II/III neurons. Additionally, subanesthetic esketamine induced inter-layer phase desynchronization and a premature increase in ACh and 5-HT levels in the PFC during the awakening process.</div></div><div><h3>Conclusion</h3><div>Our findings suggest that low-dose esketamine facilitates mice awakening from propofol anesthesia may by orchestrating a sequence of neural events in the PFC. This study provides novel mechanistic insight into the paradoxical emergence from anesthesia induced by subanesthetic esketamine/ketamine.</div></div>","PeriodicalId":9302,"journal":{"name":"Brain Research Bulletin","volume":"233 ","pages":"Article 111648"},"PeriodicalIF":3.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145596178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ATF3 promotes ferroptosis by transcriptional repression of SLC7A11 in ischemic stroke 缺血性卒中中ATF3通过抑制SLC7A11的转录促进铁下垂
IF 3.7 3区 医学 Q2 NEUROSCIENCES Pub Date : 2025-12-01 DOI: 10.1016/j.brainresbull.2025.111659
Ying He , Ying Zhao , Ruitao Mao , Wangxiang Li , Tengmin Gui , Huanhuan Ren , Shuxian Zhang , Yuan Song , Liqing Yao
Activating transcription factor 3 (ATF3) and solute carrier family 7 member 11 (SLC7A11) have been implicated in ferroptosis following ischemic stroke. However, the precise regulatory mechanisms between ATF3 and SLC7A11 remain incompletely understood. This study aims to investigate the regulatory mechanism of ATF3 and SLC7A11 in ferroptosis during ischemic stroke. The stroke-related microarray dataset GSE58294 was downloaded from the GEO database. Differential gene expression analysis was performed to identify ferroptosis-related differentially expressed genes (FRDEGs). Bioinformatics analyses, including Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment, and protein-protein interaction (PPI) network construction, were conducted. Key hub genes were validated in both a rat model of middle cerebral artery occlusion/reperfusion (MCAO/R) and a cellular model of oxygen-glucose deprivation/reoxygenation (OGD/R) using BV2 microglia. Cell viability was assessed by CCK-8 assay. Ferroptosis-related proteins were analyzed by Western blot, and apoptosis was detected by flow cytometry. Levels of reactive oxygen species (ROS) and Fe2+ were measured using immunofluorescence and ELISA, respectively. Bioinformatic analysis identified SLC7A11 as a significantly altered gene in stroke. The PPI network predicted ATF3 as a key transcription factor regulating SLC7A11. In vitro, transfection with si-ATF3 downregulated GPX4 and FTH1 levels while upregulating IREB2 and ALOX15. Furthermore, si-ATF3 transfection reduced ROS levels and iron concentration in microglia, effects that were reversed by the ferroptosis inducer erastin. Notably, SLC7A11 expression was significantly increased following ATF3 knockdown. Our findings demonstrate that ATF3 preliminarily promotes ferroptosis by binding to the SLC7A11 promoter and inhibiting its expression, providing a novel mechanistic insight into ischemic stroke pathology.
激活转录因子3 (ATF3)和溶质载体家族7成员11 (SLC7A11)与缺血性卒中后铁下垂有关。然而,ATF3和SLC7A11之间的精确调控机制仍然不完全清楚。本研究旨在探讨ATF3和SLC7A11在缺血性脑卒中中铁下垂的调控机制。从GEO数据库下载脑卒中相关微阵列数据集GSE58294。通过差异基因表达分析,鉴定与铁衰相关的差异表达基因(FRDEGs)。进行了生物信息学分析,包括基因本体(GO)、京都基因与基因组百科全书(KEGG)富集和蛋白质-蛋白质相互作用(PPI)网络构建。在大鼠大脑中动脉闭塞/再灌注(MCAO/R)模型和BV2小胶质细胞氧-葡萄糖剥夺/再氧合(OGD/R)模型中验证了关键枢纽基因。CCK-8法测定细胞活力。Western blot检测细胞凋亡相关蛋白,流式细胞术检测细胞凋亡。采用免疫荧光法和酶联免疫吸附法分别测定各组小鼠的活性氧(ROS)和铁离子(Fe2+)水平。生物信息学分析发现SLC7A11在中风中是一个显著改变的基因。PPI网络预测ATF3是调节SLC7A11的关键转录因子。在体外,转染si-ATF3可下调GPX4和FTH1水平,上调IREB2和ALOX15水平。此外,si-ATF3转染降低了小胶质细胞中的ROS水平和铁浓度,这一效应被铁下垂诱导剂erastin逆转。值得注意的是,在ATF3敲除后,SLC7A11的表达显著增加。我们的研究结果表明,ATF3通过结合SLC7A11启动子并抑制其表达,初步促进铁下垂,为缺血性卒中病理提供了新的机制见解。
{"title":"ATF3 promotes ferroptosis by transcriptional repression of SLC7A11 in ischemic stroke","authors":"Ying He ,&nbsp;Ying Zhao ,&nbsp;Ruitao Mao ,&nbsp;Wangxiang Li ,&nbsp;Tengmin Gui ,&nbsp;Huanhuan Ren ,&nbsp;Shuxian Zhang ,&nbsp;Yuan Song ,&nbsp;Liqing Yao","doi":"10.1016/j.brainresbull.2025.111659","DOIUrl":"10.1016/j.brainresbull.2025.111659","url":null,"abstract":"<div><div>Activating transcription factor 3 (ATF3) and solute carrier family 7 member 11 (SLC7A11) have been implicated in ferroptosis following ischemic stroke. However, the precise regulatory mechanisms between ATF3 and SLC7A11 remain incompletely understood. This study aims to investigate the regulatory mechanism of ATF3 and SLC7A11 in ferroptosis during ischemic stroke. The stroke-related microarray dataset GSE58294 was downloaded from the GEO database. Differential gene expression analysis was performed to identify ferroptosis-related differentially expressed genes (FRDEGs). Bioinformatics analyses, including Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment, and protein-protein interaction (PPI) network construction, were conducted. Key hub genes were validated in both a rat model of middle cerebral artery occlusion/reperfusion (MCAO/R) and a cellular model of oxygen-glucose deprivation/reoxygenation (OGD/R) using BV2 microglia. Cell viability was assessed by CCK-8 assay. Ferroptosis-related proteins were analyzed by Western blot, and apoptosis was detected by flow cytometry. Levels of reactive oxygen species (ROS) and Fe<sup>2+</sup> were measured using immunofluorescence and ELISA, respectively. Bioinformatic analysis identified SLC7A11 as a significantly altered gene in stroke. The PPI network predicted ATF3 as a key transcription factor regulating SLC7A11. In vitro, transfection with si-ATF3 downregulated GPX4 and FTH1 levels while upregulating IREB2 and ALOX15. Furthermore, si-ATF3 transfection reduced ROS levels and iron concentration in microglia, effects that were reversed by the ferroptosis inducer erastin. Notably, SLC7A11 expression was significantly increased following ATF3 knockdown. Our findings demonstrate that ATF3 preliminarily promotes ferroptosis by binding to the SLC7A11 promoter and inhibiting its expression, providing a novel mechanistic insight into ischemic stroke pathology.</div></div>","PeriodicalId":9302,"journal":{"name":"Brain Research Bulletin","volume":"233 ","pages":"Article 111659"},"PeriodicalIF":3.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145615112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multifunctionality of tissue inhibitor of metalloproteinase-1 in central nervous system diseases 金属蛋白酶-1组织抑制剂在中枢神经系统疾病中的多功能研究。
IF 3.7 3区 医学 Q2 NEUROSCIENCES Pub Date : 2025-12-01 DOI: 10.1016/j.brainresbull.2025.111647
Linke Zhong , Liuyang Zhao , Qiaoyan Tang , Xiaohua Zhang , Mingchao Zhou , Jiao Luo , Yulong Wang
Central nervous system (CNS) diseases are characterized by high morbidity, long disease courses, and irreversible neurological impairment, often resulting from damage to the neurovascular unit (NVU). Tissue inhibitor of metalloproteinase-1 (TIMP-1), the endogenous inhibitor of matrix metalloproteinase-9 (MMP-9), plays a pivotal role in maintaining extracellular matrix (ECM) homeostasis and regulating NVU integrity. Beyond its canonical MMP-inhibitory function, TIMP-1 exerts a wide spectrum of MMP-independent effects as a multifunctional cytokine that interacts with cell surface receptors such as CD63/β1-integrin and low-density lipoprotein receptor-related protein-1 (LRP-1). Through activation of FAK/PI3K–Akt and MAPK signaling pathways, TIMP-1 modulates astrocyte proliferation, neural stem cell adhesion and migration, endothelial barrier stability, and myelin regeneration. Altered TIMP-1 expression is closely associated with the onset, progression, and prognosis of major CNS disorders, including ischemic stroke, epilepsy, multiple sclerosis, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease. Accumulating evidence highlights its dual, context-dependent roles—protective in acute neuroinflammatory and ischemic injury, yet potentially profibrotic or maladaptive under chronic pathological conditions. This review comprehensively summarizes recent advances in understanding the molecular mechanisms and biological functions of TIMP-1 in CNS diseases, emphasizing its regulatory networks in neuroinflammation, neuroprotection, and neuroregeneration. A deeper understanding of TIMP-1 signaling dynamics will accelerate its translational application as a diagnostic biomarker and therapeutic target for restoring neurovascular unit function in CNS disorders.
中枢神经系统(CNS)疾病的特点是发病率高,病程长,以及不可逆的神经损伤,通常由神经血管单元(NVU)损伤引起。组织金属蛋白酶-1抑制剂(TIMP-1)是内源性基质金属蛋白酶-9 (MMP-9)抑制剂,在维持细胞外基质(ECM)稳态和调节NVU完整性中起关键作用。除了其典型的mmp抑制功能外,TIMP-1作为一种多功能细胞因子,可与细胞表面受体如CD63/β1-整合素和低密度脂蛋白受体相关蛋白-1 (LRP-1)相互作用,发挥广泛的mmp非依赖性作用。TIMP-1通过激活FAK/PI3K-Akt和MAPK信号通路,调节星形胶质细胞增殖、神经干细胞粘附和迁移、内皮屏障稳定性和髓磷脂再生。TIMP-1表达的改变与主要中枢神经系统疾病的发生、进展和预后密切相关,包括缺血性卒中、癫痫、多发性硬化症和神经退行性疾病,如阿尔茨海默病和帕金森病。越来越多的证据表明,它的双重作用,依赖于环境,在急性神经炎症和缺血性损伤中具有保护作用,但在慢性病理条件下可能会纤维化或适应不良。本文综述了TIMP-1在中枢神经系统疾病中的分子机制和生物学功能的最新研究进展,重点介绍了TIMP-1在神经炎症、神经保护和神经再生中的调控网络。对TIMP-1信号动力学的深入了解将加速其作为恢复中枢神经系统疾病中神经血管单位功能的诊断生物标志物和治疗靶点的转化应用。
{"title":"Multifunctionality of tissue inhibitor of metalloproteinase-1 in central nervous system diseases","authors":"Linke Zhong ,&nbsp;Liuyang Zhao ,&nbsp;Qiaoyan Tang ,&nbsp;Xiaohua Zhang ,&nbsp;Mingchao Zhou ,&nbsp;Jiao Luo ,&nbsp;Yulong Wang","doi":"10.1016/j.brainresbull.2025.111647","DOIUrl":"10.1016/j.brainresbull.2025.111647","url":null,"abstract":"<div><div>Central nervous system (CNS) diseases are characterized by high morbidity, long disease courses, and irreversible neurological impairment, often resulting from damage to the neurovascular unit (NVU). Tissue inhibitor of metalloproteinase-1 (TIMP-1), the endogenous inhibitor of matrix metalloproteinase-9 (MMP-9), plays a pivotal role in maintaining extracellular matrix (ECM) homeostasis and regulating NVU integrity. Beyond its canonical MMP-inhibitory function, TIMP-1 exerts a wide spectrum of MMP-independent effects as a multifunctional cytokine that interacts with cell surface receptors such as CD63/β1-integrin and low-density lipoprotein receptor-related protein-1 (LRP-1). Through activation of FAK/PI3K–Akt and MAPK signaling pathways, TIMP-1 modulates astrocyte proliferation, neural stem cell adhesion and migration, endothelial barrier stability, and myelin regeneration. Altered TIMP-1 expression is closely associated with the onset, progression, and prognosis of major CNS disorders, including ischemic stroke, epilepsy, multiple sclerosis, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease. Accumulating evidence highlights its dual, context-dependent roles—protective in acute neuroinflammatory and ischemic injury, yet potentially profibrotic or maladaptive under chronic pathological conditions. This review comprehensively summarizes recent advances in understanding the molecular mechanisms and biological functions of TIMP-1 in CNS diseases, emphasizing its regulatory networks in neuroinflammation, neuroprotection, and neuroregeneration. A deeper understanding of TIMP-1 signaling dynamics will accelerate its translational application as a diagnostic biomarker and therapeutic target for restoring neurovascular unit function in CNS disorders.</div></div>","PeriodicalId":9302,"journal":{"name":"Brain Research Bulletin","volume":"233 ","pages":"Article 111647"},"PeriodicalIF":3.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145630009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of combined entacapone and rTMS therapy on pain severity and serum inflammatory biomarkers (IL-6 and TNF-α) in Parkinson's disease 恩他卡彭联合rTMS治疗对帕金森病疼痛严重程度和血清炎症生物标志物(IL-6和TNF-α)的影响
IF 3.7 3区 医学 Q2 NEUROSCIENCES Pub Date : 2025-12-01 DOI: 10.1016/j.brainresbull.2025.111652
Yifan Yang , Jianglin Wang , Li Gao , Jiaodan Miao , Fuwei Shen , Hua Liu

Objective

To evaluate the efficacy of entacapone (EN) combined with high-frequency repetitive transcranial magnetic stimulation (rTMS) in treating pain in patients with Parkinson's disease (PD), with the primary outcome defined as the change in pain severity assessed by the Visual Analog Scale (VAS).Secondary outcomes included motor function (UPDRS), other pain dimensions (KPPS), depressive symptoms (HAMD), and levels of inflammatory markers (TNF-α and IL-6).

Methods

A total of 72 PD patients with pain were enrolled and randomly assigned to three groups: Group 1 (LD + sham stimulation), Group 2 (LD + EN + sham stimulation), and Group 3 (LD + EN + rTMS) and assessed via motor, pain, and depression scales (UPDRS/VAS/KPPS/HAMD) to evaluate the efficacy of the treatment, and also to observe the changes in the levels of interleukin (IL-6) and tumor necrosis factor (TNF-α), which are associated with pain in PD.

Results

After six months of combined pharmacotherapy and rTMS, the primary outcome, VAS score, demonstrated a significantly greater reduction in Group 3 compared to Group 2 (2.86 ± 1.25 vs. 8.22 ± 1.31, P < 0.05).In addition, from the indexes of inflammatory factors, this study found that after six months of regular and systematic treatment, the reduction in serum IL-6 and TNF-α levels was most pronounced in the combined therapy group (LD+EN+rTMS), with statistically significant differences compared to Group 2 (P = 0.003 for TNF-α).

Conclusions

High-frequency rTMS, as a non-invasive neuromodulation technique combined with EN, improves muscle rigidity, alleviates depressive symptoms, reduces pain, and attenuates inflammatory factor secretion in PD patients, can improve muscle tension, regulate depression, relieve pain, and reduce the secretion of inflammatory factors in Parkinson's patients.This combined therapy was clinically effective and demonstrated a favorable safety profile, with no serious adverse events reported and only mild, transient side effects (e.g., scalp discomfort, headache) observed in the rTMS group. However, its long-term efficacy requires further investigation.
目的:评价恩他卡酮(EN)联合高频重复经颅磁刺激(rTMS)治疗帕金森病(PD)患者疼痛的疗效,以视觉模拟量表(VAS)评估疼痛严重程度的变化为主要终点。次要结局包括运动功能(UPDRS)、其他疼痛维度(KPPS)、抑郁症状(HAMD)和炎症标志物(TNF-α和IL-6)水平。方法:总共有72 PD患者痛苦是注册和随机分为三组:第1组(LD +假刺激),组2 (LD + EN +假刺激)和组3 (LD + EN + rTMS)通过电动机和评估,痛苦,和抑郁量表(UPDRS /血管/ KPPS / HAMD)来评估治疗的疗效,并观察白介素(il - 6)水平的变化和肿瘤坏死因子(TNF -α),在PD与疼痛有关。结果:经药物联合rTMS治疗6个月后,第3组VAS评分明显低于第2组(2.86±1.25比8.22±1.31,P < 0.05)。此外,从炎症因子指标来看,本研究发现,经过6个月的常规系统治疗后,血清IL-6和TNF-α水平的降低以LD+EN+rTMS联合治疗组最为明显,与2组比较差异有统计学意义(TNF-α P = 0.003)。结论:高频rTMS作为一种无创神经调节技术,结合EN可改善PD患者肌肉强直、缓解抑郁症状、减轻疼痛、减轻炎症因子分泌,可改善帕金森患者肌肉紧张、调节抑郁、缓解疼痛、减少炎症因子分泌。这种联合治疗在临床上是有效的,并且具有良好的安全性,在rTMS组中没有严重的不良事件报告,只有轻微的、短暂的副作用(例如,头皮不适、头痛)。然而,其长期疗效有待进一步研究。
{"title":"Effects of combined entacapone and rTMS therapy on pain severity and serum inflammatory biomarkers (IL-6 and TNF-α) in Parkinson's disease","authors":"Yifan Yang ,&nbsp;Jianglin Wang ,&nbsp;Li Gao ,&nbsp;Jiaodan Miao ,&nbsp;Fuwei Shen ,&nbsp;Hua Liu","doi":"10.1016/j.brainresbull.2025.111652","DOIUrl":"10.1016/j.brainresbull.2025.111652","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the efficacy of entacapone (EN) combined with high-frequency repetitive transcranial magnetic stimulation (rTMS) in treating pain in patients with Parkinson's disease (PD), with the primary outcome defined as the change in pain severity assessed by the Visual Analog Scale (VAS).Secondary outcomes included motor function (UPDRS), other pain dimensions (KPPS), depressive symptoms (HAMD), and levels of inflammatory markers (TNF-α and IL-6).</div></div><div><h3>Methods</h3><div>A total of 72 PD patients with pain were enrolled and randomly assigned to three groups: Group 1 (LD + sham stimulation), Group 2 (LD + EN + sham stimulation), and Group 3 (LD + EN + rTMS) and assessed via motor, pain, and depression scales (UPDRS/VAS/KPPS/HAMD) to evaluate the efficacy of the treatment, and also to observe the changes in the levels of interleukin (IL-6) and tumor necrosis factor (TNF-α), which are associated with pain in PD.</div></div><div><h3>Results</h3><div>After six months of combined pharmacotherapy and rTMS, the primary outcome, VAS score, demonstrated a significantly greater reduction in Group 3 compared to Group 2 (2.86 ± 1.25 vs. 8.22 ± 1.31, P &lt; 0.05).In addition, from the indexes of inflammatory factors, this study found that after six months of regular and systematic treatment, the reduction in serum IL-6 and TNF-α levels was most pronounced in the combined therapy group (LD+EN+rTMS), with statistically significant differences compared to Group 2 (P = 0.003 for TNF-α).</div></div><div><h3>Conclusions</h3><div>High-frequency rTMS, as a non-invasive neuromodulation technique combined with EN, improves muscle rigidity, alleviates depressive symptoms, reduces pain, and attenuates inflammatory factor secretion in PD patients, can improve muscle tension, regulate depression, relieve pain, and reduce the secretion of inflammatory factors in Parkinson's patients.This combined therapy was clinically effective and demonstrated a favorable safety profile, with no serious adverse events reported and only mild, transient side effects (e.g., scalp discomfort, headache) observed in the rTMS group. However, its long-term efficacy requires further investigation.</div></div>","PeriodicalId":9302,"journal":{"name":"Brain Research Bulletin","volume":"233 ","pages":"Article 111652"},"PeriodicalIF":3.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145602602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abnormal functional integration and effective connectivity in striatal-cortical networks with neurotransmitter system correlates in migraine without aura: A resting-state fMRI study 无先兆偏头痛的纹状体-皮层网络与神经递质系统的异常功能整合和有效连接:静息状态fMRI研究
IF 3.7 3区 医学 Q2 NEUROSCIENCES Pub Date : 2025-12-01 DOI: 10.1016/j.brainresbull.2025.111653
Zhiyang Zhang , Chaorong Xie , Linglin Dong , Xu Ouyang , Xixiu Ni , Mingsheng Sun , Qixuan Fu , Qinyi Yan , Qiang Zhang , Xiao Wang , Ling Zhao

Background

Migraine without aura (MWoA) is linked to abnormal subcortical/cortical network activity and neurotransmitter dysregulation. However, the alteration of functional integration and the information flow between brain networks participated in pain sensory pathway and the patterns of neurotransmitter dysregulation during the interictal period remain unclear.

Methods

This cross-sectional study compared 53 interictal MWoA patients and 51 healthy controls using resting-state fMRI. Whole-brain functional integration (degree centrality, DC) and effective connectivity (EC) were analyzed. JuSpace toolbox mapped spatial correlation between functional alterations and neurotransmitter systems.

Results

MWoA patients showed decreased DC in the left putamen and increased DC in the left angular gyrus. Altered EC from subcortical to cortical regions included pathways from the left putamen to right medial superior frontal gyrus, supramarginal gyrus, dorsolateral superior frontal gyrus, and postcentral gyrus, as well as bilateral caudate to left angular gyrus. Cortical-to-subcortical EC changes involved right dorsolateral superior frontal gyrus to left putamen and left angular gyrus to left caudate. EC from left putamen to right postcentral gyrus inversely correlated with headache frequency, while right caudate to left angular gyrus EC positively correlated with disease duration. Altered DC patterns spatially overlapped with serotonergic, dopaminergic, and glutamate pathways and correlated with quality-of-life impairments (MSQ scores).

Conclusion

MWoA involves disrupted functional integration and bidirectional subcortical-cortical connectivity during interictal periods, associated with headache severity and neurotransmitter system imbalances. These findings highlight network-level pathophysiology and neurochemical dysregulation underlying migraine.
无先兆偏头痛(MWoA)与皮层下/皮层网络活动异常和神经递质失调有关。然而,痛觉通路参与脑网络之间的功能整合和信息流的改变,以及神经递质在间隙期的失调模式尚不清楚。方法采用静息态fMRI对53例间期MWoA患者和51例健康对照进行横断面研究。分析了全脑功能整合(度中心性,DC)和有效连通性(EC)。JuSpace工具箱绘制了功能改变与神经递质系统之间的空间相关性。结果smwoa患者表现为左壳核DC减少,左角回DC增加。皮层下至皮质区的EC改变包括左壳核至右内侧额上回、边缘上回、背外侧额上回、中央后回以及双侧尾状回至左角回的通路。皮层到皮层下的EC变化包括右背外侧额上回到左壳核和左角回到左尾状核。从左壳核到右中央后回的脑电图与头痛频率呈负相关,而从右尾状核到左角回的脑电图与病程呈正相关。改变的DC模式在空间上与血清素、多巴胺和谷氨酸通路重叠,并与生活质量受损相关(MSQ评分)。结论mwoa与头痛的严重程度和神经递质系统失衡有关,包括功能整合和皮质下-皮质双向连接的中断。这些发现强调了网络水平的病理生理和神经化学失调的潜在偏头痛。
{"title":"Abnormal functional integration and effective connectivity in striatal-cortical networks with neurotransmitter system correlates in migraine without aura: A resting-state fMRI study","authors":"Zhiyang Zhang ,&nbsp;Chaorong Xie ,&nbsp;Linglin Dong ,&nbsp;Xu Ouyang ,&nbsp;Xixiu Ni ,&nbsp;Mingsheng Sun ,&nbsp;Qixuan Fu ,&nbsp;Qinyi Yan ,&nbsp;Qiang Zhang ,&nbsp;Xiao Wang ,&nbsp;Ling Zhao","doi":"10.1016/j.brainresbull.2025.111653","DOIUrl":"10.1016/j.brainresbull.2025.111653","url":null,"abstract":"<div><h3>Background</h3><div>Migraine without aura (MWoA) is linked to abnormal subcortical/cortical network activity and neurotransmitter dysregulation. However, the alteration of functional integration and the information flow between brain networks participated in pain sensory pathway and the patterns of neurotransmitter dysregulation during the interictal period remain unclear.</div></div><div><h3>Methods</h3><div>This cross-sectional study compared 53 interictal MWoA patients and 51 healthy controls using resting-state fMRI. Whole-brain functional integration (degree centrality, DC) and effective connectivity (EC) were analyzed. JuSpace toolbox mapped spatial correlation between functional alterations and neurotransmitter systems.</div></div><div><h3>Results</h3><div>MWoA patients showed decreased DC in the left putamen and increased DC in the left angular gyrus. Altered EC from subcortical to cortical regions included pathways from the left putamen to right medial superior frontal gyrus, supramarginal gyrus, dorsolateral superior frontal gyrus, and postcentral gyrus, as well as bilateral caudate to left angular gyrus. Cortical-to-subcortical EC changes involved right dorsolateral superior frontal gyrus to left putamen and left angular gyrus to left caudate. EC from left putamen to right postcentral gyrus inversely correlated with headache frequency, while right caudate to left angular gyrus EC positively correlated with disease duration. Altered DC patterns spatially overlapped with serotonergic, dopaminergic, and glutamate pathways and correlated with quality-of-life impairments (MSQ scores).</div></div><div><h3>Conclusion</h3><div>MWoA involves disrupted functional integration and bidirectional subcortical-cortical connectivity during interictal periods, associated with headache severity and neurotransmitter system imbalances. These findings highlight network-level pathophysiology and neurochemical dysregulation underlying migraine.</div></div>","PeriodicalId":9302,"journal":{"name":"Brain Research Bulletin","volume":"233 ","pages":"Article 111653"},"PeriodicalIF":3.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145615563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Brain Research Bulletin
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1